Model for end-stage liver disease-Na score or Maddrey discrimination function index, which score is best?

World Journal of Hepatology

Volumn 7, Issue 17, 2015, Pages 2119-2126

  Amieva Balmori, Mercedes ^a   Mejia Loza, Scherezada María Isabel ^a   Ramos González, Roberto ^a   Zamarripa Dorsey, Felipe ^a   García Ruiz, Eli ^a   Pérez y López, Nuria ^a   Juárez Valdés, Eumir I ^a   López Luria, Adriana ^a   Remes Troche, José María ^a  

^a UNIVERSIDAD VERACRUZANA   (Mexico)

Author keywords

Alcoholic hepatitis; Maddrey; Model for end stage liver disease Na; Mortality

Indexed keywords

EID: 84939140955     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v7.i17.2119     Document Type: Article

References (40)

1. Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, Saveria Crocè L, Sasso F, Pozzato G, Cristianini G, Brandi G. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 1997; 41: 845-850 [PMID: 9462221]
2. Becker U, Deis A, Sørensen TI, Grønbaek M, Borch-Johnsen K, Müller CF, Schnohr P, Jensen G. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996; 23: 1025-1029 [PMID: 8621128 DOI: 10.1002/hep.510230513]
3. Altamirano J, Higuera-de laTijera F, Duarte-Rojo A, Martínez-Vázquez MA, Abraldes JG, Herrera-Jiménez LE, Michelena J, Zapata L, Perez-Hernández J, Torre A, Gonzáles-González JA, Cardenas A, Dominguez M, Arroyo V, Ginès P, Caballería J, Bataller R. The amount of alcohol consumption negatively impacts short-term mortality in Mexican patients with alcoholic hepatitis. Am J Gastroenterol 2011; 106: 1472-1480 [PMID: 21556041 DOI: 10.1038/ajg.2011.141]
4. Choi G, Runyon BA. Alcoholic hepatitis: a clinician's guide. Clin Liver Dis 2012; 16: 371-385 [PMID: 22541704 DOI: 10.1016/j.cld.2012.03.015]
5. Singal AK, Shah VH. Alcoholic hepatitis: prognostic models and treatment. Gastroenterol Clin North Am 2011; 40: 611-639 [PMID:21893277 DOI: 10.1016/j.gtc.2011.06.008]
6. Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med 2009; 360: 2758-2769 [PMID: 19553649 DOI: 10.1056/nejmra0805786]
7. Maddrey WC, Boitnott JK, Bedine MS, Weber FL, Mezey E, White RI. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75: 193-199 [PMID: 352788]
8. Forrest EH, Evans CD, Stewart S, Phillips M, Oo YH, McAvoy NC, Fisher NC, Singhal S, Brind A, Haydon G, O'Grady J, Day CP, Hayes PC, Murray LS, Morris AJ. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut 2005; 54: 1174-1179 [PMID: 16009691]
9. Dominguez M, Rincón D, Abraldes JG, Miquel R, Colmenero J, Bellot P, García-Pagán JC, Fernández R, Moreno M, Bañares R, Arroyo V, Caballería J, Ginès P, Bataller R. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am J Gastroenterol 2008; 103: 2747-2756 [PMID: 18721242 DOI: 10.1111/j.1572-0241.2008.02104.x]
10. Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, Fartoux L, Dharancy S, Texier F, Hollebecque A, Serfaty L, Boleslawski E, Deltenre P, Canva V, Pruvot FR, Mathurin P. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 2007; 45: 1348-1354 [PMID: 17518367 DOI: 10.1002/hep.21607]
11. Dunn W, Jamil LH, Brown LS, Wiesner RH, Kim WR, Menon KV, Malinchoc M, Kamath PS, Shah V. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology 2005; 41:353-358 [PMID: 15660383 DOI: 10.1002/hep.20503]
12. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470 [PMID: 11172350 DOI: 10.1053/jhep.2001.22172]
13. Mathurin P, Lucey MR. Management of alcoholic hepatitis. J Hepatol 2012; 56 Suppl 1: S39-S45 [PMID: 22300464 DOI: 10.1016/S0168-8278(12)60005-1]
14. Sheth M, Riggs M, Patel T. Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol 2002; 2: 2 [PMID:11835693 DOI: 10.1186/1471-230X-2-2]
15. Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, Lucey MR. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004; 40: 897-903 [PMID: 15158328 DOI: 10.1016/j.jhep.2004.02.010]
16. Kadian M, Kakkar R, Dhar M, Kaushik RM. Model for end-stage liver disease score versus Maddrey discriminant function score in assessing short-term outcome in alcoholic hepatitis. J Gastroenterol Hepatol 2014; 29: 581-588 [PMID: 24117536 DOI: 10.1111/jgh.12400]
17. Monsanto P, Almeida N, Lrias C, Pina JE, Sofia C. Evaluation of MELD score and Maddrey discriminant function for mortality prediction in patients with alcoholic hepatitis. Hepatogastroenterology 2013; 60: 1089-1094 [PMID: 23803373 DOI: 10.5754/hge11969]
18. Yang Y, Deng L, Li X, Shi Z, Chen D, Chen X, Li M, Ma L. Evaluation of the prognosis of fulminant viral hepatitis in late pregnancy by the MELD scoring system. Eur J Clin Microbiol Infect Dis 2012; 31: 2673-2678 [PMID: 22569645 DOI: 10.1007/s10096-012-1613-y]
19. Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Chiou YY, Lui WY, Lee PC, Lee SD. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey. Dig Liver Dis 2008; 40: 882-889 [PMID: 18339595 DOI: 10.1016/j.dld.2008.01.015]
20. Khalaf H, Mourad W, El-Sheikh Y, Abdo A, Helmy A, Medhat Y, Al-Sofayan M, Al-Sagheir M, Al-Sebayel M. Liver transplantation for autoimmune hepatitis: a single-center experience. Transplant Proc 2007; 39: 1166-1170 [PMID: 17524922 DOI: 10.1016/j.trans proceed.2007.02.030]
21. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006; 130: 1652-1660 [PMID: 16697729 DOI: 10.1053/j.gastro.2006.02.010]
22. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005; 11: 336-343 [PMID: 15719386 DOI: 10.1002/lt.20329]
23. Srikureja W, Kyulo NL, Runyon BA, Hu KQ. MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis. J Hepatol 2005; 42: 700-706 [PMID: 15826720 DOI: 10.1016/j.jhep.2004.12.022]
24. Papastergiou V, Tsochatzis EA, Pieri G, Thalassinos E, Dhar A, Bruno S, Karatapanis S, Luong TV, O'Beirne J, Patch D, Thorburn D, Burroughs AK. Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort. Aliment Pharmacol Ther 2014; 39: 721-732 [PMID: 24612165 DOI: 10.1111/apt.12654]
25. Kasztelan-Szczerbinska B, Slomka M, Celinski K, Szczerbinski M. Alkaline phosphatase: the next independent predictor of the poor 90-day outcome in alcoholic hepatitis. Biomed Res Int 2013; 2013: 614081 [PMID: 24151614 DOI: 10.1155/2013/614081]
26. Vaa BE, Asrani SK, Dunn W, Kamath PS, Shah VH. Influence of serum sodium on MELD-based survival prediction in alcoholic hepatitis. Mayo Clin Proc 2011; 86: 37-42 [PMID: 21193654 DOI: 10.4065/mcp.2010.0281]
27. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-843 [PMID: 6878708 DOI: 10.1148/radiology.148.3.6878708]
28. Méndez-Sánchez N, Aguilar-Ramírez JR, Reyes A, Dehesa M, Juórez A, Castñeda B, Sánchez-Avila F, Poo JL, Guevara González L, Lizardi J, Valdovinos MA, Uribe M, Contreras AM, Tirado P, Aguirre J, Rivera-Benítez C, Santiago-Santiago R, Bosques-Padilla F, Muñoz L, Guerroro A, Ramos M, Rodríguez-Hernández H, Jacobo-Karam J. Etiology of liver cirrhosis in Mexico. Ann Hepatol 2004; 3: 30-33 [PMID: 15118577]
29. Orrego H, Blake JE, Blendis LM, Medline A. Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology 1987; 92: 208-214 [PMID: 3781189]
30. Christoffersen P, Nielsen K. Histological changes in human liver biopsies from chronic alcoholics. Acta Pathol Microbiol Scand A 1972; 80: 557-565 [PMID: 5056834 DOI: 10.1111/j.1699-0463.1972. tb00316.x]
31. Trabut JB, Plat A, Thepot V, Fontaine H, Vallet-Pichard A, Nalpas B, Pol S. Influence of liver biopsy on abstinence in alcoholdependent patients. Alcohol Alcohol 2008; 43: 559-563 [PMID:18621800 DOI: 10.1093/alcalc/agn046]
32. Jinjuvadia R, Liangpunsakul S. Trends in Alcoholic Hepatitisrelated Hospitalizations, Financial Burden, and Mortality in the United States. J Clin Gastroenterol 2015; 49: 506-511 [PMID: 25198164]
33. Gordillo-Bastidas E, Panduro A, Gordillo-Bastidas D, Zepeda-Carrillo EA, García-Bañuelos JJ, Muñoz-Valle JF, Bastidas-Ramírez BE. Polymorphisms of alcohol metabolizing enzymes in indigenous Mexican population: unusual high frequency of CYP2E1*c2 allele. Alcohol Clin Exp Res 2010; 34: 142-149 [PMID: 19860798 DOI: 10.1111/j.1530-0277.2009.01075.x]
34. Montano Loza AJ, Ramirez Iglesias MT, Perez Diaz I, Cruz Castellanos S, Garcia Andrade C, Medina Mora ME, Robles Díaz G, Kershenobich D, Gutierrez Reyes G. Association of alcoholmetabolizing genes with alcoholism in a Mexican Indian (Otomi) population. Alcohol 2006; 39: 73-79 [PMID: 17134659 DOI: 10.1016/j.alcohol.2006.07.001]
35. Lafferty H, Stanley AJ, Forrest EH. The management of alcoholic hepatitis: a prospective comparison of scoring systems. Aliment Pharmacol Ther 2013; 38: 603-610 [PMID: 23879668 DOI: 10.1111/apt.12414]
36. Ginès P, Guevara M. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology 2008; 48:1002-1010 [PMID: 18671303 DOI: 10.1002/hep.22418]
37. Murphy N, Auzinger G, Bernel W, Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004; 39: 464-470 [PMID:14767999 DOI: 10.1002/hep.20056]
38. Larsen FS, Wendon J. Prevention and management of brain edema in patients with acute liver failure. Liver Transpl 2008; 14 Suppl 2:S90-S96 [PMID: 18825686 DOI: 10.1002/lt.21643]
39. Ramond MJ, Poynard T, Rueff B, Mathurin P, Théodore C, Chaput JC, Benhamou JP. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992; 326:507-512 [PMID: 1531090 DOI: 10.1056/NEJM199202203260802]
40. Spahr L, Rubbia-Brandt L, Pugin J, Giostra E, Frossard JL, Borisch B, Hadengue A. Rapid changes in alcoholic hepatitis histology under steroids: correlation with soluble intercellular adhesion molecule-1 in hepatic venous blood. J Hepatol 2001; 35: 582-589 [PMID: 11690703 DOI: 10.1016/S0168-8278(01)00190-8]